24 recherche sur le mot-clé 'Treatment Outcome'

Dynamic Eye Tracking as a Predictor and Outcome Measure of Social Skills Intervention in Adolescents and Adults with Autism Spectrum Disorder / Rachel K. GREENE in Journal of Autism and Developmental Disorders, 51-4 (April 2021)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 51-4 (April 2021) . - p.1173-1187 Titre : Dynamic Eye Tracking as a Predictor and Outcome Measure of Social Skills Intervention in Adolescents and Adults with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Rachel K. GREENE, Auteur ; Julia PARISH-MORRIS, Auteur ; Miranda SULLIVAN, Auteur ; Jessica L. KINARD, Auteur ; Maya G MOSNER, Auteur ; Lauren M. TURNER-BROWN, Auteur ; David L. PENN, Auteur ; Christopher A. WIESEN, Auteur ; Ashley A. PALLATHRA, Auteur ; Edward S. BRODKIN, Auteur ; Robert T. SCHULTZ, Auteur ; Gabriel S. DICHTER, Auteur Article en page(s) : p.1173-1187 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  Eye tracking  Social skills intervention  Treatment outcome Index. décimale : PER Périodiques Résumé : To evaluate an eye tracking task as a predictor and outcome measure of treatment response for autism spectrum disorder (ASD) social skills interventions, adolescents and young adults with ASD completed the eye tracking task before, immediately after, and two months after completing Social Cognition and Interaction Training for Autism (SCIT-A). The study compared SCIT-A participants (n?=?20) to participants with ASD who received treatment as usual (TAU; n?=?21). Overall, increased visual attention to faces and background objects and decreased attention to hands playing with toys at baseline were associated with improved social functioning immediately following intervention, suggesting this eye tracking task may reliably predict ASD social intervention outcomes. En ligne : http://dx.doi.org/10.1007/s10803-020-04594-1 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445 [article] Dynamic Eye Tracking as a Predictor and Outcome Measure of Social Skills Intervention in Adolescents and Adults with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Rachel K. GREENE, Auteur ; Julia PARISH-MORRIS, Auteur ; Miranda SULLIVAN, Auteur ; Jessica L. KINARD, Auteur ; Maya G MOSNER, Auteur ; Lauren M. TURNER-BROWN, Auteur ; David L. PENN, Auteur ; Christopher A. WIESEN, Auteur ; Ashley A. PALLATHRA, Auteur ; Edward S. BRODKIN, Auteur ; Robert T. SCHULTZ, Auteur ; Gabriel S. DICHTER, Auteur . - p.1173-1187. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 51-4 (April 2021) . - p.1173-1187 Mots-clés : Autism spectrum disorder  Eye tracking  Social skills intervention  Treatment outcome Index. décimale : PER Périodiques Résumé : To evaluate an eye tracking task as a predictor and outcome measure of treatment response for autism spectrum disorder (ASD) social skills interventions, adolescents and young adults with ASD completed the eye tracking task before, immediately after, and two months after completing Social Cognition and Interaction Training for Autism (SCIT-A). The study compared SCIT-A participants (n?=?20) to participants with ASD who received treatment as usual (TAU; n?=?21). Overall, increased visual attention to faces and background objects and decreased attention to hands playing with toys at baseline were associated with improved social functioning immediately following intervention, suggesting this eye tracking task may reliably predict ASD social intervention outcomes. En ligne : http://dx.doi.org/10.1007/s10803-020-04594-1 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=445

Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design / Lotte HENDRIKS in Journal of Child Psychology and Psychiatry, 58-11 (November 2017)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 58-11 (November 2017) . - p.1229-1238 Titre : Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design Type de document : Texte imprimé et/ou numérique Auteurs : Lotte HENDRIKS, Auteur ; Rianne A. DE KLEINE, Auteur ; Mieke HEYVAERT, Auteur ; Eni S. BECKER, Auteur ; Gert-Jan HENDRIKS, Auteur ; Agnes VAN MINNEN, Auteur Article en page(s) : p.1229-1238 Langues : Anglais (eng) Mots-clés : Complex PTSD  treatment outcome  adolescents  prolonged exposure  intensive treatment Index. décimale : PER Périodiques Résumé : Background The current study evaluated the effectiveness and safety of intensive prolonged exposure (PE) targeting adolescent patients with complex posttraumatic stress disorder (PTSD) and comorbid disorders following multiple interpersonal trauma. Methods Ten adolescents meeting full diagnostic criteria for PTSD were recruited from a specialized outpatient mental health clinic and offered a standardized intensive PE. The intensive PE consisted of three daily 90-min exposure sessions delivered on five consecutive weekdays, followed by 3 weekly 90-min booster sessions. In a single-trial design, the participants were randomly allocated to one of five baseline lengths (4–8 weeks) before starting the intensive PE. Before, during, and after intensive PE completion, self-reported PTSD symptom severity was assessed weekly as a primary outcome (a total of 21 measurements). Furthermore, clinician-administered PTSD diagnostic status and symptom severity (primary outcome), as well as self-reported comorbid symptoms (secondary outcomes), were assessed at four single time points (baseline-to-6-month follow-up). Results Time-series analyses showed that self-reported PTSD symptom severity significantly declined following treatment (p = .002). Pre-postgroup analyses demonstrated significant reductions of clinician-administered PTSD symptom severity and self-reported comorbidity that persisted during the 3- and 6-month follow-ups (all ps < .05), where 80% of adolescents had reached diagnostic remission of PTSD. There was neither treatment dropout nor any adverse events. Conclusions The results of this first proof of concept trial suggest that intensive PE can be effective and safe in an adolescent population with complex PTSD, although the gains achieved need to be confirmed in a randomized controlled trial. En ligne : http://dx.doi.org/10.1111/jcpp.12756 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=326 [article] Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design [Texte imprimé et/ou numérique] / Lotte HENDRIKS, Auteur ; Rianne A. DE KLEINE, Auteur ; Mieke HEYVAERT, Auteur ; Eni S. BECKER, Auteur ; Gert-Jan HENDRIKS, Auteur ; Agnes VAN MINNEN, Auteur . - p.1229-1238. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 58-11 (November 2017) . - p.1229-1238 Mots-clés : Complex PTSD  treatment outcome  adolescents  prolonged exposure  intensive treatment Index. décimale : PER Périodiques Résumé : Background The current study evaluated the effectiveness and safety of intensive prolonged exposure (PE) targeting adolescent patients with complex posttraumatic stress disorder (PTSD) and comorbid disorders following multiple interpersonal trauma. Methods Ten adolescents meeting full diagnostic criteria for PTSD were recruited from a specialized outpatient mental health clinic and offered a standardized intensive PE. The intensive PE consisted of three daily 90-min exposure sessions delivered on five consecutive weekdays, followed by 3 weekly 90-min booster sessions. In a single-trial design, the participants were randomly allocated to one of five baseline lengths (4–8 weeks) before starting the intensive PE. Before, during, and after intensive PE completion, self-reported PTSD symptom severity was assessed weekly as a primary outcome (a total of 21 measurements). Furthermore, clinician-administered PTSD diagnostic status and symptom severity (primary outcome), as well as self-reported comorbid symptoms (secondary outcomes), were assessed at four single time points (baseline-to-6-month follow-up). Results Time-series analyses showed that self-reported PTSD symptom severity significantly declined following treatment (p = .002). Pre-postgroup analyses demonstrated significant reductions of clinician-administered PTSD symptom severity and self-reported comorbidity that persisted during the 3- and 6-month follow-ups (all ps < .05), where 80% of adolescents had reached diagnostic remission of PTSD. There was neither treatment dropout nor any adverse events. Conclusions The results of this first proof of concept trial suggest that intensive PE can be effective and safe in an adolescent population with complex PTSD, although the gains achieved need to be confirmed in a randomized controlled trial. En ligne : http://dx.doi.org/10.1111/jcpp.12756 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=326

Long-term follow-up of a randomized controlled trial comparing systemic family therapy (FT-S) added to treatment as usual (TAU) with TAU alone in adolescents with anorexia nervosa / Nathalie GODART in Journal of Child Psychology and Psychiatry, 63-11 (November 2022)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 63-11 (November 2022) . - p.1368-1380 Titre : Long-term follow-up of a randomized controlled trial comparing systemic family therapy (FT-S) added to treatment as usual (TAU) with TAU alone in adolescents with anorexia nervosa Type de document : Texte imprimé et/ou numérique Auteurs : Nathalie GODART, Auteur ; Géraldine DORARD, Auteur ; Jeanne DUCLOS, Auteur ; FLORENCE CURT, Auteur ; Irène KAGANSKI, Auteur ; Lisa MINIER, Auteur ; Maurice CORCOS, Auteur ; Bruno FALISSARD, Auteur ; Ivan EISLER, Auteur ; Philippe JEAMMET, Auteur ; Sylvie BERTHOZ, Auteur Article en page(s) : p.1368-1380 Langues : Anglais (eng) Mots-clés : Female  Adolescent  Humans  Anorexia Nervosa/therapy  Family Therapy/methods  Follow-Up Studies  Feeding and Eating Disorders  Ambulatory Care  Treatment Outcome  Randomized Controlled Trials as Topic  Anorexia nervosa  long-term follow-up  outcome  systemic family therapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Randomized controlled trials showed the efficacy of family therapy for anorexia nervosa during adolescence, but studies examining its long-term beneficial effect are still needed. This article presents the results of a 54-month post-randomization follow-up of a previously reported randomized controlled trial that compared two post-hospitalization outpatient treatment programs: Treatment As Usual alone versus Systemic Family Therapy added to Treatment As Usual. METHODS: A consecutive series of 60 female adolescents with anorexia nervosa (DSM-IV) were randomized (30 per group). During the first 18 months, in the Treatment As Usual group, subjects received a multidisciplinary treatment. In the other group, Systemic Family Therapy sessions targeting intra-familial dynamics were added to Treatment As Usual. At 54 months, the primary outcome was defined using the Morgan and Russell global Outcome Categories (Good or Intermediate versus Poor). Secondary outcomes were the Global Outcome Assessment Schedule score, body mass index, amenorrhea, number of hospitalizations, eating disorder symptoms, psychopathological features, and family functioning. Analyses were carried out using an Intention-To-Treat with the Last Observation Carried Forward procedure. Data of 59/60 subjects were available. RESULTS: At 54 months, significant effects in favor of adding Systemic Family Therapy to Treatment As Usual were shown for the Global Outcome Categories (60% of Good/Intermediate versus 31% in the control group, p=.026), mean body mass index (p=.048), resumption of menses (70.0% vs. 40% p=.020), and mental state score (p=.010). Family cohesion scores were lower in the Systemic Family Therapy group (p = .040). CONCLUSIONS: Adding Systemic Family Therapy focusing on intra-familial dynamics to a multidimensional outpatient treatment program appeared to lead to a better long-term outcome in young women who suffered from severe anorexia nervosa during adolescence. En ligne : http://dx.doi.org/10.1111/jcpp.13583 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=490 [article] Long-term follow-up of a randomized controlled trial comparing systemic family therapy (FT-S) added to treatment as usual (TAU) with TAU alone in adolescents with anorexia nervosa [Texte imprimé et/ou numérique] / Nathalie GODART, Auteur ; Géraldine DORARD, Auteur ; Jeanne DUCLOS, Auteur ; FLORENCE CURT, Auteur ; Irène KAGANSKI, Auteur ; Lisa MINIER, Auteur ; Maurice CORCOS, Auteur ; Bruno FALISSARD, Auteur ; Ivan EISLER, Auteur ; Philippe JEAMMET, Auteur ; Sylvie BERTHOZ, Auteur . - p.1368-1380. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 63-11 (November 2022) . - p.1368-1380 Mots-clés : Female  Adolescent  Humans  Anorexia Nervosa/therapy  Family Therapy/methods  Follow-Up Studies  Feeding and Eating Disorders  Ambulatory Care  Treatment Outcome  Randomized Controlled Trials as Topic  Anorexia nervosa  long-term follow-up  outcome  systemic family therapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Randomized controlled trials showed the efficacy of family therapy for anorexia nervosa during adolescence, but studies examining its long-term beneficial effect are still needed. This article presents the results of a 54-month post-randomization follow-up of a previously reported randomized controlled trial that compared two post-hospitalization outpatient treatment programs: Treatment As Usual alone versus Systemic Family Therapy added to Treatment As Usual. METHODS: A consecutive series of 60 female adolescents with anorexia nervosa (DSM-IV) were randomized (30 per group). During the first 18 months, in the Treatment As Usual group, subjects received a multidisciplinary treatment. In the other group, Systemic Family Therapy sessions targeting intra-familial dynamics were added to Treatment As Usual. At 54 months, the primary outcome was defined using the Morgan and Russell global Outcome Categories (Good or Intermediate versus Poor). Secondary outcomes were the Global Outcome Assessment Schedule score, body mass index, amenorrhea, number of hospitalizations, eating disorder symptoms, psychopathological features, and family functioning. Analyses were carried out using an Intention-To-Treat with the Last Observation Carried Forward procedure. Data of 59/60 subjects were available. RESULTS: At 54 months, significant effects in favor of adding Systemic Family Therapy to Treatment As Usual were shown for the Global Outcome Categories (60% of Good/Intermediate versus 31% in the control group, p=.026), mean body mass index (p=.048), resumption of menses (70.0% vs. 40% p=.020), and mental state score (p=.010). Family cohesion scores were lower in the Systemic Family Therapy group (p = .040). CONCLUSIONS: Adding Systemic Family Therapy focusing on intra-familial dynamics to a multidimensional outpatient treatment program appeared to lead to a better long-term outcome in young women who suffered from severe anorexia nervosa during adolescence. En ligne : http://dx.doi.org/10.1111/jcpp.13583 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=490

Assessment and Treatment of Noise Hypersensitivity in a Teenager with Autism Spectrum Disorder: A Case Study / J. C. FODSTAD in Journal of Autism and Developmental Disorders, 51-6 (June 2021)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 51-6 (June 2021) . - p.1811-1822 Titre : Assessment and Treatment of Noise Hypersensitivity in a Teenager with Autism Spectrum Disorder: A Case Study Type de document : Texte imprimé et/ou numérique Auteurs : J. C. FODSTAD, Auteur ; S. A. KERSWILL, Auteur ; A. C. KIRSCH, Auteur ; A. LAGGES, Auteur ; J. SCHMIDT, Auteur Article en page(s) : p.1811-1822 Langues : Anglais (eng) Mots-clés : Adaptation, Psychological  Adolescent  Anxiety/psychology  Autism Spectrum Disorder/psychology  Avoidance Learning  Cognitive Behavioral Therapy/methods  Humans  Hyperacusis/diagnosis/psychology/therapy  Intellectual Disability/psychology  Male  Problem Behavior/psychology  Treatment Outcome  Anxiety  Autism spectrum disorder  Cognitive behavior therapy  Noise hypersensitivity  Problem behaviors  Systematic desensitization Index. décimale : PER Périodiques Résumé : Noise hypersensitivity is a poorly understood symptom of Autism Spectrum Disorder (ASD). For some, problem behaviors co-occur with the aversive noise. Limited literature exists on treating noise hypersensitivity; however, noise hypersensitivity may be related to a specific phobia. This case study utilizes modified Cognitive Behavioral Therapy (CBT) to address anxiety, avoidance, and problem behaviors evoked by noise in a teen with ASD and mild Intellectual Disability (ID). Using multi-method assessment and individualized treatment, problem behaviors reduced, and independent coping strategies use occurred. Successful desensitization supports the efficacy of modified CBT as a treatment for noise-related anxiety and problem behaviors in individuals with ASD and ID. Outcomes are discussed considering intervention difficulties for noise hypersensitivity in a complex and diverse population. En ligne : http://dx.doi.org/10.1007/s10803-020-04650-w Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452 [article] Assessment and Treatment of Noise Hypersensitivity in a Teenager with Autism Spectrum Disorder: A Case Study [Texte imprimé et/ou numérique] / J. C. FODSTAD, Auteur ; S. A. KERSWILL, Auteur ; A. C. KIRSCH, Auteur ; A. LAGGES, Auteur ; J. SCHMIDT, Auteur . - p.1811-1822. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 51-6 (June 2021) . - p.1811-1822 Mots-clés : Adaptation, Psychological  Adolescent  Anxiety/psychology  Autism Spectrum Disorder/psychology  Avoidance Learning  Cognitive Behavioral Therapy/methods  Humans  Hyperacusis/diagnosis/psychology/therapy  Intellectual Disability/psychology  Male  Problem Behavior/psychology  Treatment Outcome  Anxiety  Autism spectrum disorder  Cognitive behavior therapy  Noise hypersensitivity  Problem behaviors  Systematic desensitization Index. décimale : PER Périodiques Résumé : Noise hypersensitivity is a poorly understood symptom of Autism Spectrum Disorder (ASD). For some, problem behaviors co-occur with the aversive noise. Limited literature exists on treating noise hypersensitivity; however, noise hypersensitivity may be related to a specific phobia. This case study utilizes modified Cognitive Behavioral Therapy (CBT) to address anxiety, avoidance, and problem behaviors evoked by noise in a teen with ASD and mild Intellectual Disability (ID). Using multi-method assessment and individualized treatment, problem behaviors reduced, and independent coping strategies use occurred. Successful desensitization supports the efficacy of modified CBT as a treatment for noise-related anxiety and problem behaviors in individuals with ASD and ID. Outcomes are discussed considering intervention difficulties for noise hypersensitivity in a complex and diverse population. En ligne : http://dx.doi.org/10.1007/s10803-020-04650-w Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) / V. CRUTEL in Journal of Autism and Developmental Disorders, 51-8 (August 2021)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 51-8 (August 2021) . - p.2959-2972 Titre : Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) Type de document : Texte imprimé et/ou numérique Auteurs : V. CRUTEL, Auteur ; E. LAMBERT, Auteur ; P. F. PENELAUD, Auteur ; C. ALBARRÁN SEVERO, Auteur ; J. FUENTES, Auteur ; A. ROSIER, Auteur ; A. HERVAS, Auteur ; S. MARRET, Auteur ; G. OLIVEIRA, Auteur ; Mara PARELLADA, Auteur ; S. KYAGA, Auteur ; S. GOUTTEFANGEAS, Auteur ; M. BERTRAND, Auteur ; D. RAVEL, Auteur ; B. FALISSARD, Auteur Article en page(s) : p.2959-2972 Langues : Anglais (eng) Mots-clés : Adolescent  Autism Spectrum Disorder/drug therapy  Bumetanide/administration & dosage/therapeutic use  Child  Child, Preschool  Double-Blind Method  Humans  Male  Research Design  Social Behavior  Treatment Outcome  Autism spectrum disorder  Bumetanide  Pediatrics  Randomized controlled trial  for Actelion, Allergan, Almirall, Astellas, AstraZeneca, Bayer, Biotronik, BMS,  Boehringer Ingelheim, Daiichi- Sankyo, Eli Lilly, Genzyme, Gilead, Grunenthal, GSK,  HRA, Janssen, Lundbeck, MSD, Novartis, Otsuka, Pierre Fabre, Roche, Sanofi, Servier,  Stallergene, UCB, ViiV. JF has received research support from Servier and  AIMS-2-Trials project ID 777394. DR is an employee of Neurochlore. GO, SM, AR, AH,  and MP report no conflict of interest. Index. décimale : PER Périodiques Résumé : There are currently no approved pharmacological treatments to improve social reciprocity and limit repetitive and rigid behaviors in autism spectrum disorder (ASD). We describe the design of two Phase III studies evaluating the efficacy/safety of bumetanide oral liquid formulation in ASD. These are international, multicenter, randomized, double-blind, placebo-controlled studies in children and adolescents with ASD aged 7 to 17 years (n?=?200; study 1), or younger children with ASD aged 2 to 6 years (n?=?200; study 2). The primary endpoint of each is change in Childhood Autism Rating Scale 2 total raw score after 6 months. These studies could contribute to the first pharmacological treatment to improve social reciprocity and limit repetitive and rigid behaviors in children and adolescents with ASD. En ligne : http://dx.doi.org/10.1007/s10803-020-04709-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=453 [article] Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) [Texte imprimé et/ou numérique] / V. CRUTEL, Auteur ; E. LAMBERT, Auteur ; P. F. PENELAUD, Auteur ; C. ALBARRÁN SEVERO, Auteur ; J. FUENTES, Auteur ; A. ROSIER, Auteur ; A. HERVAS, Auteur ; S. MARRET, Auteur ; G. OLIVEIRA, Auteur ; Mara PARELLADA, Auteur ; S. KYAGA, Auteur ; S. GOUTTEFANGEAS, Auteur ; M. BERTRAND, Auteur ; D. RAVEL, Auteur ; B. FALISSARD, Auteur . - p.2959-2972. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 51-8 (August 2021) . - p.2959-2972 Mots-clés : Adolescent  Autism Spectrum Disorder/drug therapy  Bumetanide/administration & dosage/therapeutic use  Child  Child, Preschool  Double-Blind Method  Humans  Male  Research Design  Social Behavior  Treatment Outcome  Autism spectrum disorder  Bumetanide  Pediatrics  Randomized controlled trial  for Actelion, Allergan, Almirall, Astellas, AstraZeneca, Bayer, Biotronik, BMS,  Boehringer Ingelheim, Daiichi- Sankyo, Eli Lilly, Genzyme, Gilead, Grunenthal, GSK,  HRA, Janssen, Lundbeck, MSD, Novartis, Otsuka, Pierre Fabre, Roche, Sanofi, Servier,  Stallergene, UCB, ViiV. JF has received research support from Servier and  AIMS-2-Trials project ID 777394. DR is an employee of Neurochlore. GO, SM, AR, AH,  and MP report no conflict of interest. Index. décimale : PER Périodiques Résumé : There are currently no approved pharmacological treatments to improve social reciprocity and limit repetitive and rigid behaviors in autism spectrum disorder (ASD). We describe the design of two Phase III studies evaluating the efficacy/safety of bumetanide oral liquid formulation in ASD. These are international, multicenter, randomized, double-blind, placebo-controlled studies in children and adolescents with ASD aged 7 to 17 years (n?=?200; study 1), or younger children with ASD aged 2 to 6 years (n?=?200; study 2). The primary endpoint of each is change in Childhood Autism Rating Scale 2 total raw score after 6 months. These studies could contribute to the first pharmacological treatment to improve social reciprocity and limit repetitive and rigid behaviors in children and adolescents with ASD. En ligne : http://dx.doi.org/10.1007/s10803-020-04709-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=453

Collateral Effects of Behavioral Treatment for Problem Behavior on Caregiver Stress / P. F. KURTZ in Journal of Autism and Developmental Disorders, 51-8 (August 2021)  

Permalink

Early Intensive Behavioral Interventions: Selecting behaviors for treatment and assessing treatment effectiveness / Johnny L. MATSON in Research in Autism Spectrum Disorders, 8-2 (February 2014)  

Permalink

Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants / Arjun P. ATHREYA in Journal of Child Psychology and Psychiatry, 63-11 (November 2022)  

Permalink

A Longitudinal Study of Language Trajectories and Treatment Outcomes of Early Intensive Behavioral Intervention for Autism / T. W. FRAZIER in Journal of Autism and Developmental Disorders, 51-12 (December 2021)  

Permalink

Moderators of response to child-based and parent-based child anxiety treatment: a machine learning-based analysis / E. R. LEBOWITZ in Journal of Child Psychology and Psychiatry, 62-10 (October 2021)  

Permalink